Florida Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.

Press releases published on August 14, 2026

Aug. 14, 2026

Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 14, 2026

Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update 

Indeterminate GlobeNewswire

Aug. 14, 2026

 Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress

Indeterminate GlobeNewswire

Aug. 14, 2026

Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis

Indeterminate GlobeNewswire

Aug. 14, 2026

Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences

Indeterminate GlobeNewswire

Aug. 14, 2026

JOYY to Announce Second Quarter 2026 Financial Results on August 25, 2026

Indeterminate GlobeNewswire

Aug. 14, 2026

Aurora Mobile and Exabytes Sign Three-Year Strategic MoU to Bring AI-Powered Customer Engagement to Businesses Across Southeast Asia

Indeterminate GlobeNewswire

Aug. 14, 2026

Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 14, 2026

Diginex and Resulticks Sign Amended Definitive Agreement to Create a Global AI-Powered Group Spanning Customer Engagement and Trusted Sustainability Data

Indeterminate GlobeNewswire

Aug. 14, 2026

Kodiak AI Receives DMV Permit to Test Autonomous Trucks in California

Indeterminate GlobeNewswire

Aug. 14, 2026

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Indeterminate GlobeNewswire

Aug. 14, 2026

Pfizer et Valneva annoncent l’acceptation pour revue par l’Agence européenne des médicaments (EMA) de la demande d’autorisation de mise sur le marché de leur candidat vaccin contre la maladie de Lyme

Indeterminate GlobeNewswire

Aug. 14, 2026

Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering

Indeterminate GlobeNewswire